Literature DB >> 19498430

Alzheimer disease: Perceived efficacy of antidementia drug treatment.

Kevina McAvinchey1, Alistair Burns.   

Abstract

Investigators in Germany have solicited the views of neurologists and psychiatrists on the effectiveness of antidementia drug treatments. The study concludes that clinicians generally consider these treatments to be beneficial, and that the provision of support to caregivers seems to further enhance the perceived benefits.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19498430     DOI: 10.1038/nrneurol.2009.56

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  5 in total

1.  Alarming arbitrariness in EU prescription and reimbursement criteria for anti-dementia drugs.

Authors:  Richard C Oude Voshaar; Alistair Burns; Marcel G M Olde Rikkert
Journal:  Int J Geriatr Psychiatry       Date:  2006-01       Impact factor: 3.485

Review 2.  Access to diagnostic evaluation and treatment for dementia in Europe.

Authors:  Gunhild Waldemar; Kieu T T Phung; Alistair Burns; Jean Georges; Finn Ronholt Hansen; Steven Iliffe; Christine Marking; Marcel Olde Rikkert; Jacques Selmes; Gabriela Stoppe; Norman Sartorius
Journal:  Int J Geriatr Psychiatry       Date:  2007-01       Impact factor: 3.485

3.  Neurological and psychiatric practitioners' views on Alzheimer's disease and treatment thereof.

Authors:  M W Riepe; B Ibach
Journal:  Dement Geriatr Cogn Disord       Date:  2008-12-04       Impact factor: 2.959

Review 4.  Alzheimer's disease.

Authors:  Alistair Burns; Steve Iliffe
Journal:  BMJ       Date:  2009-02-05

5.  The National Dementia strategy in England.

Authors:  Alistair Burns; Philippe Robert
Journal:  BMJ       Date:  2009-03-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.